Randall Michael Giuffre Dia Medica Therapeutics Inc. (DMAC) insider trading activity

Randall Michael Giuffre is Director of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 392,412 shares of DMAC, which is worth approximately $2.56 Million. The most recent transaction as insider was on Feb 13, 2025, when has been sold 17,000 shares (Voting Common Shares, no par value per share) at a price of $2.88 per share, resulting in proceeds of $48,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 392K

7.64% 3M change

7.64% 12M change

Total Value Held $2.56 Million

Randall Michael Giuffre Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 13 2025	BUY Exercise of conversion of derivative security	$48,960 $2.88 p/Share	17,000 Added 4.15%	392,412 Voting Common Shares, ...
Jan 02 2025	BUY Grant, award, or other acquisition	$57,997 $5.34 p/Share	10,861 Added 2.81%	375,412 Voting Common Shares, ...
Jan 02 2024	BUY Grant, award, or other acquisition	$53,748 $2.8 p/Share	19,196 Added 5.0%	364,551 Voting Common Shares, ...
Jun 23 2023	SELL Bona fide gift	-	15,000 Reduced 4.16%	345,355 Voting Common Shares, ...
Jun 23 2023	BUY Open market or private purchase	$254,150 $3.91 p/Share	65,000 Added 15.28%	360,355 Voting Common Shares, ...
Jan 03 2023	BUY Grant, award, or other acquisition	$53,748 $1.53 p/Share	35,130 Added 10.63%	295,355 Voting Common Shares, ...
Dec 09 2022	BUY Open market or private purchase	$53,022 $1.43 p/Share	37,079 Added 12.47%	260,225 Voting Common Shares, ...
Dec 08 2022	BUY Open market or private purchase	$28,000 $1.4 p/Share	20,000 Added 8.23%	223,146 Voting Common Shares, ...
Dec 07 2022	BUY Open market or private purchase	$31,603 $1.4 p/Share	22,574 Added 10.0%	203,146 Voting Common Shares, ...
Dec 06 2022	BUY Open market or private purchase	$3,105 $1.35 p/Share	2,300 Added 1.26%	180,572 Voting Common Shares, ...
Dec 01 2022	BUY Open market or private purchase	$974 $1.19 p/Share	819 Added 0.46%	178,272 Voting Common Shares, ...
Dec 01 2022	BUY Open market or private purchase	$55,359 $1.2 p/Share	46,133 Added 20.63%	177,453 Voting Common Shares, ...
Nov 30 2022	BUY Open market or private purchase	$3,534 $1.19 p/Share	2,970 Added 2.21%	131,320 Voting Common Shares, ...
Nov 29 2022	BUY Open market or private purchase	$21,568 $1.19 p/Share	18,125 Added 12.37%	128,350 Voting Common Shares, ...
Jan 03 2022	BUY Grant, award, or other acquisition	$53,793 $3.58 p/Share	15,026 Added 12.0%	110,225 Voting Common Shares, ...
Jan 01 2021	BUY Grant, award, or other acquisition	$61,239 $8.23 p/Share	7,441 Added 6.03%	116,029 Voting Common Shares, ...
Nov 20 2020	BUY Open market or private purchase	$63,900 $4.26 p/Share	15,000 Added 12.14%	108,588 Voting Common Shares, ...

RMG

Randall Michael Giuffre

Director

Minneapolis, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Value

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

Operation

Value

Type

News

Receive news related to DiaMedica Therapeutics Inc.

Track Activities on DMAC

Account